Login / Signup

Long-Term Persistence of Serum-Specific Anti-Chikungunya IgM Antibody - A Case Series of Brazilian Patients.

Denise Maria do Nascimento CostaMaria Rosângela Cunha Duarte CoêlhoPedro Alves da Cruz GouveiaLuan Araújo BezerraClaudia Diniz Lopes MarquesÂngela Luzia Branco Pinto DuarteLucila Maria ValenteVera Magalhães
Published in: Revista da Sociedade Brasileira de Medicina Tropical (2021)
The persistence of serum-specific anti-chikungunya IgM antibodies (CHIKV-IgM) can vary after chikungunya fever (CHIK) infection. However, the factors related to its production are not yet known. We described a case series drawn up from data collected from 57 patients between 12 and 36 months after the acute phase of CHIK infection in Northeastern Brazil. CHIKV-IgM was detectable in 7/57 (12.3%) patients after 28.3 months of infection. No frequency differences in chronic musculoskeletal manifestations and underlying conditions were detected between patients with or without CHIKV-IgM. CHIKV-IgM was detected for up to 35 months in Brazilian patients after CHIK infection.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • prognostic factors
  • peritoneal dialysis
  • patient reported outcomes
  • big data
  • aedes aegypti